Literature DB >> 24512211

Estimation of polyclonal IgG4 hybrids in normal human serum.

Elizabeth Young1, Emma Lock, Douglas G Ward, Alexander Cook, Stephen Harding, Gregg L F Wallis.   

Abstract

The in vivo or in vitro formation of IgG4 hybrid molecules, wherein the immunoglobulins have exchanged half molecules, has previously been reported under experimental conditions. Here we estimate the incidence of polyclonal IgG4 hybrids in normal human serum and comment on the existence of IgG4 molecules with different immunoglobulin light chains. Polyclonal IgG4 was purified from pooled or individual donor human sera and sequentially fractionated using light-chain affinity and size exclusion chromatography. Fractions were analysed by SDS-PAGE, immunoblotting, ELISA, immunodiffusion and matrix-assisted laser-desorption mass spectrometry. Polyclonal IgG4 purified from normal serum contained IgG4κ, IgG4λ and IgG4κ/λ molecules. Size exclusion chromatography showed that IgG4 was principally present in monomeric form (150 000 MW). SDS-PAGE, immunoblotting and ELISA showed the purity of the three IgG4 samples. Immunodiffusion, light-chain sandwich ELISA and mass spectrometry demonstrated that both κ and λ light chains were present on only the IgG4κ/λ molecules. The amounts of IgG4κ/λ hybrid molecules ranged from 21 to 33% from the five sera analysed. Based on the molecular weight these molecules were formed of two IgG4 heavy chains plus one κ and one λ light chain. Polyclonal IgG (IgG4-depleted) was similarly fractionated according to light-chain specificity. No evidence of hybrid IgG κ/λ antibodies was observed. These results indicate that hybrid IgG4κ/λ antibodies compose a substantial portion of IgG4 from normal human serum.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  Fab-arm exchange; IgG4; kappa; lambda; polyclonal

Mesh:

Substances:

Year:  2014        PMID: 24512211      PMCID: PMC4080956          DOI: 10.1111/imm.12265

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  Molecular characterization of immunoglobulin G4 gene isoallotypes.

Authors:  A Brusco; S Saviozzi; F Cinque; M DeMarchi; C Boccazzi; G de Lange; A M van Leeuwen; A O Carbonara
Journal:  Eur J Immunogenet       Date:  1998-10

Review 2.  IgG4 breaking the rules.

Authors:  Rob C Aalberse; Janine Schuurman
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

3.  Medical and technical usefulness of measurement of kappa and lambda immunoglobulin light chains in serum with an M-component.

Authors:  M M Lievens
Journal:  J Clin Chem Clin Biochem       Date:  1989-08

4.  The inter-heavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bonds.

Authors:  J Schuurman; G J Perdok; A D Gorter; R C Aalberse
Journal:  Mol Immunol       Date:  2001-01       Impact factor: 4.407

5.  Fc-Fc interactions of human IgG4 require dissociation of heavy chains and are formed predominantly by the intra-chain hinge isomer.

Authors:  Theo Rispens; Joyce Meesters; Tamara H den Bleker; Pleuni Ooijevaar-De Heer; Janine Schuurman; Paul W H I Parren; Aran Labrijn; Rob C Aalberse
Journal:  Mol Immunol       Date:  2012-07-10       Impact factor: 4.407

Review 6.  Disulfide bond structures of IgG molecules: structural variations, chemical modifications and possible impacts to stability and biological function.

Authors:  Hongcheng Liu; Kimberly May
Journal:  MAbs       Date:  2012 Jan-Feb       Impact factor: 5.857

7.  Measurement of serum IgG4 levels by a competitive immunoenzymatic assay with monoclonal antibodies.

Authors:  P Aucouturier; F Danon; M Daveau; B Guillou; A Sabbah; J Besson; J L Preud'homme
Journal:  J Immunol Methods       Date:  1984-11-16       Impact factor: 2.303

Review 8.  Analysis of glutathione: implication in redox and detoxification.

Authors:  Anna Pastore; Giorgio Federici; Enrico Bertini; Fiorella Piemonte
Journal:  Clin Chim Acta       Date:  2003-07-01       Impact factor: 3.786

9.  Fab-arm exchange: what's in a name?

Authors:  Janine Schuurman; Aran F Labrijn; Paul W H I Parren
Journal:  MAbs       Date:  2012-09-06       Impact factor: 5.857

10.  Fab-arm exchange is a misnomer.

Authors:  Janardan P Pandey
Journal:  MAbs       Date:  2012-08-14       Impact factor: 5.857

View more
  10 in total

1.  Hybrid kappa\lambda antibody is a new serological marker to diagnose autoimmune pancreatitis and differentiate it from pancreatic cancer.

Authors:  Mingju Hao; Wenli Li; Lang Yi; Songlin Yu; Gaowei Fan; Tian Lu; Xin Yang; Guojing Wang; Dong Zhang; Jiansheng Ding; Kuo Zhang; Rui Zhang; Guigao Lin; Yanxi Han; Lunan Wang; Jinming Li
Journal:  Sci Rep       Date:  2016-06-08       Impact factor: 4.379

2.  The Properties of Cysteine-Conjugated Antibody-Drug Conjugates Are Impacted by the IgG Subclass.

Authors:  Amita Datta-Mannan; Hiuwan Choi; David Stokell; Jason Tang; Anthony Murphy; Aaron Wrobleski; Yiqing Feng
Journal:  AAPS J       Date:  2018-09-25       Impact factor: 4.009

3.  Natural Mosquito-Pathogen Hybrid IgG4 Antibodies in Vector-Borne Diseases: A Hypothesis.

Authors:  Berlin Londono-Renteria; Jenny C Cardenas; Andrea Troupin; Tonya M Colpitts
Journal:  Front Immunol       Date:  2016-09-29       Impact factor: 7.561

Review 4.  Potential Mechanisms for IgG4 Inhibition of Immediate Hypersensitivity Reactions.

Authors:  Louisa K James; Stephen J Till
Journal:  Curr Allergy Asthma Rep       Date:  2016-03       Impact factor: 4.806

Review 5.  A New Classification System for IgG4 Autoantibodies.

Authors:  Inga Koneczny
Journal:  Front Immunol       Date:  2018-02-12       Impact factor: 7.561

6.  Functional relevance of in vivo half antibody exchange of an IgG4 therapeutic antibody-drug conjugate.

Authors:  Peter Herbener; Kurt Schönfeld; Martin König; Matthias Germer; Jude M Przyborski; Katrin Bernöster; Jörg Schüttrumpf
Journal:  PLoS One       Date:  2018-04-19       Impact factor: 3.240

Review 7.  IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies.

Authors:  Inga Koneczny; John Tzartos; Marina Mané-Damas; Vuslat Yilmaz; Maartje G Huijbers; Konstantinos Lazaridis; Romana Höftberger; Erdem Tüzün; Pilar Martinez-Martinez; Socrates Tzartos; Frank Leypoldt
Journal:  Front Immunol       Date:  2022-03-24       Impact factor: 7.561

8.  Increased Kappa/Lambda Hybrid Antibody in Serum Is a Novel Biomarker Related to Disease Activity and Inflammation in Rheumatoid Arthritis.

Authors:  Lang Yi; Mingju Hao; Tian Lu; Guigao Lin; Lida Chen; Ming Gao; Gaowei Fan; Dong Zhang; Guojing Wang; Xin Yang; Yulong Li; Kuo Zhang; Rui Zhang; Yanxi Han; Lunan Wang; Jinming Li
Journal:  Mediators Inflamm       Date:  2016-04-06       Impact factor: 4.711

Review 9.  Human IgG4: a structural perspective.

Authors:  Anna M Davies; Brian J Sutton
Journal:  Immunol Rev       Date:  2015-11       Impact factor: 12.988

Review 10.  Immunoglobulin G; structure and functional implications of different subclass modifications in initiation and resolution of allergy.

Authors:  Timothy H Scott-Taylor; Stefan-Claudiu Axinia; Sumeya Amin; Ruth Pettengell
Journal:  Immun Inflamm Dis       Date:  2017-11-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.